1
Refgene group Array 1,135,54 9 DMR n=4,75 1 Hyper 1,373 (28.9%) Hypo 3,199 (67.3%) Fold enrichme nt CGI-PROMOTER 66,059 31 8 (25%) 23 0.11 NON CGI PROMOTER 55,693 169 35 (20%) 134 0.72 3’ GENE BODY 303,150 1,335 539 (40%) 796 1.05 GENE BODY 1040 4 1 (25%) 3 1.0 5’ GENE BODY 174,306 758 242 (31%) 516 1.27 INTERGENIC 286,802 1,445 307 (21%) 1,138 1.2 INTERGENIC/REP SEQ 53,363 192 44 (23%) 148 0.85 INTERGENIC/ALU, L1 107,603 208 48 (23%) 160 0.42 Supplemental figur

Supplemental figure 4

Embed Size (px)

DESCRIPTION

Supplemental figure 4. - PowerPoint PPT Presentation

Citation preview

Page 1: Supplemental figure 4

Refgene group Array 1,135,549

DMR n=4,751

Hyper 1,373

(28.9%)

Hypo 3,199

(67.3%)Fold

enrichment

CGI-PROMOTER 66,059 31 8 (25%) 23 0.11

NON CGI PROMOTER 55,693 169 35 (20%) 134 0.72

3’ GENE BODY 303,150 1,335 539 (40%) 796 1.05

GENE BODY 1040 4 1 (25%) 3 1.0

5’ GENE BODY 174,306 758 242 (31%) 516 1.27

INTERGENIC 286,802 1,445 307 (21%) 1,138 1.2

INTERGENIC/REP SEQ 53,363 192 44 (23%) 148 0.85

INTERGENIC/ALU, L1 107,603 208 48 (23%) 160 0.42

Supplemental figure 4

Supplemental figure 2

Supplemental figure 2

Documents
Supplemental Figure Legends

Supplemental Figure Legends

Documents
Supplemental Tables and Supplemental Figure Legends...2014/04/14  · 1 Supplemental Tables and Supplemental Figure Legends 2 3 Supplementary Figure Legends 4 5 Figure S1. SDS-PAGE

Supplemental Tables and Supplemental Figure Legends...2014/04/14  · 1 Supplemental Tables and Supplemental Figure Legends 2 3 Supplementary Figure Legends 4 5 Figure S1. SDS-PAGE

Documents
Supplement Supplemental Figures and Supplemental Figure

Supplement Supplemental Figures and Supplemental Figure

Documents
Figure Legends for Supplemental Figures Supplemental

Figure Legends for Supplemental Figures Supplemental

Documents
Collected Supplemental Figures Marginsgenesdev.cshlp.org/content/suppl/2007/10/01/21.19.2448.DC1/... · Supplemental Figure 2 Supplemental Figure 4 Supplemental Figure 5 Supplemental

Collected Supplemental Figures Marginsgenesdev.cshlp.org/content/suppl/2007/10/01/21.19.2448.DC1/... · Supplemental Figure 2 Supplemental Figure 4 Supplemental Figure 5 Supplemental

Documents
Supplemental Figure 1 A B C - dm5migu4zj3pb.cloudfront.netdm5migu4zj3pb.cloudfront.net/manuscripts/74000/74349/JCI74349s… · Supplemental Figure 4 A B Iso/PE - + + + Exog. cAMP

Supplemental Figure 1 A B C - dm5migu4zj3pb.cloudfront.netdm5migu4zj3pb.cloudfront.net/manuscripts/74000/74349/JCI74349s… · Supplemental Figure 4 A B Iso/PE - + + + Exog. cAMP

Documents
Supplemental Figure Legends: Supplemental Figure S1 ...genesdev.cshlp.org/content/suppl/2014/07/11/gad... · Supplemental Figure Legends: Supplemental Figure S1 Vernalization response

Supplemental Figure Legends: Supplemental Figure S1 ...genesdev.cshlp.org/content/suppl/2014/07/11/gad... · Supplemental Figure Legends: Supplemental Figure S1 Vernalization response

Documents
Supplemental Figure 3

Supplemental Figure 3

Documents
Supplemental Figure Legend Supplemental Figure 1 ... · Supplemental Figure 4. Recombinant factors needed to be applied in cocktail form to achieve nuclear translocation. Nuclear

Supplemental Figure Legend Supplemental Figure 1 ... · Supplemental Figure 4. Recombinant factors needed to be applied in cocktail form to achieve nuclear translocation. Nuclear

Documents
Supplemental Figure S1

Supplemental Figure S1

Documents
Supplemental Figures S1-S8. Supplemental Figure S1

Supplemental Figures S1-S8. Supplemental Figure S1

Documents
Supplemental Figures Supplemental Figure 1€¦ · Supplemental Figures . Supplemental Figure 1 . Supplemental Figure 1. AdipoChaser mouse models used for cold and thermoneutral exposures

Supplemental Figures Supplemental Figure 1€¦ · Supplemental Figures . Supplemental Figure 1 . Supplemental Figure 1. AdipoChaser mouse models used for cold and thermoneutral exposures

Documents
Supplemental Figure 1

Supplemental Figure 1

Documents
Supplemental Figure S 4

Supplemental Figure S 4

Documents
Supplemental Digital Content Supplemental Figure 1

Supplemental Digital Content Supplemental Figure 1

Documents
1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

Documents
SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell ...genesdev.cshlp.org/.../Supplemental_Figures.pdf · 6.02.2017  · SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell

SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell ...genesdev.cshlp.org/.../Supplemental_Figures.pdf · 6.02.2017  · SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell

Documents
Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B

Documents
Supplemental Figure 1 A. · Supplemental Figure 1 A. B. Let-7 target site C. miR-103/107 target site . 2 Supplemental Figure 2 . 3 Supplemental Figure 3 . 4 Supplemental Figure 4

Supplemental Figure 1 A. · Supplemental Figure 1 A. B. Let-7 target site C. miR-103/107 target site . 2 Supplemental Figure 2 . 3 Supplemental Figure 3 . 4 Supplemental Figure 4

Documents
Supplemental Figure 1

Supplemental Figure 1

Documents
Supplemental Figure Legends: Supplemental Figure 1 ...dm5migu4zj3pb.cloudfront.net/manuscripts/59000/59743/JCI...31 Supplemental Figure Legends: Supplemental Figure 1. Caerulein treatment

Supplemental Figure Legends: Supplemental Figure 1 ...dm5migu4zj3pb.cloudfront.net/manuscripts/59000/59743/JCI...31 Supplemental Figure Legends: Supplemental Figure 1. Caerulein treatment

Documents
Supplemental Figure S1

Supplemental Figure S1

Documents
Undifferentiated Differentiated (4 d) Supplemental Figure S1

Undifferentiated Differentiated (4 d) Supplemental Figure S1

Documents
Supplemental Figure 1

Supplemental Figure 1

Documents
Supplemental Figure 5

Supplemental Figure 5

Documents
Supplemental Figure S5

Supplemental Figure S5

Documents
Supplemental Figure Legend Supplemental Figure 1 A · Supplemental Figure Legend Supplemental Figure 1 (A) Principal component analysis of gene expression of Panc-1 and BxPC3 cells.All

Supplemental Figure Legend Supplemental Figure 1 A · Supplemental Figure Legend Supplemental Figure 1 (A) Principal component analysis of gene expression of Panc-1 and BxPC3 cells.All

Documents
Supplemental Figure 2 - Cancer Discovery · SUPPLEMENTAL FIGURE 2. Title: Supplemental Figure 2 Created Date: 7/29/2016 10:43:37 AM

Supplemental Figure 2 - Cancer Discovery · SUPPLEMENTAL FIGURE 2. Title: Supplemental Figure 2 Created Date: 7/29/2016 10:43:37 AM

Documents
Figure I supplemental

Figure I supplemental

Documents